Literature DB >> 1793044

Contribution of the monocyte to thrombotic potential.

C R Spillert1, E J Lazaro.   

Abstract

The circulating monocyte exhibits the capacity to initiate and accelerate the coagulation cascade. We have devised a simple whole blood clotting assay which quantitates the monocyte's contribution of procoagulant (a marker of monocyte activation) to the clotting process and in addition, measures the in vivo activation of the cell. Citrated whole blood is added to saline and the recalcification time (RT) determined without incubation (RT control), with two hours incubation (RT saline), or added to endotoxin with incubation (RT endotoxin). The reduction in value between RT control and RT saline is a measure of monocyte activation in vivo. The reduction in time between RT saline and RT endotoxin is a marker of monocyte activation in vitro. This simple test enables the measurement of monocyte activation and this cells contribution to the hypercoagulability described in many disease states.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1793044     DOI: 10.1007/bf01993228

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  7 in total

1.  Direct correlation between injury severity and two markers of the functional status of the immune system.

Authors:  J N McCullough; C R Spillert; E J Lazaro
Journal:  Circ Shock       Date:  1990-07

2.  The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin.

Authors:  B Osterud; E Bjørklid
Journal:  Scand J Haematol       Date:  1982-08

3.  Hypercoagulability in arterial disease.

Authors:  C R Spillert; V J Milazzo; W D Suval; E J Lazaro
Journal:  Angiology       Date:  1989-10       Impact factor: 3.619

4.  An assessment of monocyte procoagulant activity in patients with solid tumors.

Authors:  K S Dasmahapatra; N K Cheung; C Spillert; E Lazaro
Journal:  J Surg Res       Date:  1987-08       Impact factor: 2.192

5.  Prediction of clinical course in diabetes using a simple coagulation test.

Authors:  C R Spillert; V J Milazzo; J A Pastena; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1989-01       Impact factor: 1.798

6.  Assessment of monocyte function in breast disease.

Authors:  C R Spillert; G T Curtis; E J Lazaro
Journal:  South Med J       Date:  1988-02       Impact factor: 0.954

7.  Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation.

Authors:  R L Edwards; F R Rickles; M Cronlund
Journal:  J Lab Clin Med       Date:  1981-12
  7 in total
  3 in total

1.  Altered coagulability: an aid to selective breast biopsy.

Authors:  C R Spillert; M R Passannante; J E Salzer-Pagan; E J Lazaro
Journal:  J Natl Med Assoc       Date:  1993-04       Impact factor: 1.798

2.  Prothrombotic effects of endothelin-2 (ET-2).

Authors:  G W Raff; C R Spillert; D J Wilson; E J Lazaro
Journal:  Agents Actions       Date:  1993

3.  Coagulation effects of cyclosporine in liver transplantation.

Authors:  R J Ferrante; C R Spillert; D J Wilson; E J Lazaro
Journal:  Agents Actions       Date:  1993
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.